by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
Before starting peptide treatment, a comprehensive blood panel is essential and typically includes a complete blood count, metabolic panel, liver and kidney function tests, fasting glucose and insulin levels, HbA1c, full hormonal profile including testosterone,...
by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
Peptides for weight loss, such as Semaglutide (Wegovy) and Tirzepatide (Zepbound), are highly effective, FDA-approved, or commonly used medications that mimic hormones to reduce appetite, increase satiety, and regulate blood sugar. These weekly injections typically...
by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
Retatrutide injections currently have no fixed commercial price in India because the drug has not yet received regulatory approval for retail sale. Cost is determined by the source of the compound, the dosage required, how many injections the protocol involves, and...
by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
Retatrutide (reta) peptide causes side effects, primarily mild-to-moderate gastrointestinal issues like nausea, diarrhea, vomiting, and constipation. These are most common during initial dose escalation. While generally safe in trials, potential less common side...
by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
No, retatrutide is not commercially available in India as an approved drug yet. It is currently in Phase 3 clinical trials globally and has not received regulatory approval from India’s CDSCO or the US FDA for commercial sale as of now. However,...